Papers › G2DR: A Genotype-First Framework for Genetics-Informed Target Prioritization and Drug...
G2DR: A Genotype-First Framework for Genetics-Informed Target Prioritization and Drug Repurposing
Muhammad Muneeb, David B. Ascher
Title, abstract, authors and date from arXiv's metadata (CC0); this paper is not in the Papers with Code archive (frozen 2025-07-28).
Human genetics offers a promising route to therapeutic discovery, yet practical frameworks translating genotype-derived signal into ranked target and drug hypotheses remain limited, particularly when matched disease transcriptomics are unavailable. Here we present G2DR, a genotype-first prioritization framework propagating inherited variation through genetically predicted expression, multi-method gene-level testing, pathway enrichment, network context, druggability, and multi-source drug--target evidence integration. In a migraine case study with 733 UK Biobank participants under stratified five-fold cross-validation, we imputed expression across seven transcriptome-weight resources and ranked genes using a reproducibility-aware discovery score from training and validation data, followed by a balanced integrated score for target selection. Discovery-based prioritization generalized to held-out data, achieving gene-level ROC-AUC of 0.775 and PR-AUC of 0.475, while retaining enrichment for curated migraine biology. Mapping prioritized genes to compounds via Open Targets, DGIdb, and ChEMBL yielded drug sets enriched for migraine-linked compounds relative to a global background, though recovery favoured broader mechanism-linked and off-label space over migraine-specific approved therapies. Directionality filtering separated broadly recovered compounds from mechanistically compatible candidates. G2DR is a modular framework for genetics-informed hypothesis generation, not a clinically actionable recommendation system. All outputs require independent experimental, pharmacological, and clinical validation.
In Syntology Open this paper in Syntology's Atlas, the map of the papers in Syntology's graph and their citations.
Code
Reachability, where shown, is from one Syntology probe window (2026-09-16 to 2026-09-18); repositories not probed show nothing. GitHub stars are not tracked.
Code Syntology ran Syntology
Syntology holds the repository link but has not harvested or run code from it.
Results from the paper
The Papers with Code archive ends with its 2025-07-28 snapshot. This paper's arXiv identifier, 2603.20346, was issued in March 2026, after that date, so the archive has no leaderboard rows for it.
Report a problem or propose a change · a person checks every report against the paper or source before anything changes; decisions are listed on /corrections